$-0.01 EPS Expected for Pharma-Bio Serv, Inc. (PBSV) as of June, 13

May 17, 2018 - By Victoria Pittman

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Corporate Logo

Earnings report for Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) is awaited on June, 13., according to RTT. Last year’s EPS was $-0.01, while now analysts expect change of 0.00 % from current $-0.01 EPS. Lastly it traded at $0.6.Since May 17, 2017 it’s 0.00% down thus . The stock underperformed the S&P 500 by 11.55%.

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil.The firm is worth $13.84 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support.Currently it has negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.